Table 1.
Patient demographics, CTM findings, subsequent interventions, and clinical follow-up. Positive findings are highlighted in bold. R: right; L: left; FOV: field of view; NST: nerve sheath tear; CVF: CSF-venous fistula; BP: blood patch; h/a: headache.
| Gender (M/F) | Age | Side down | CTM findings | Renal contrast | Time b/w DSM-CT (min) | Intervention (BP, ligation, embolization) | F/U after intervention (days) | Symptom improvement |
|---|---|---|---|---|---|---|---|---|
| M | 52 | R | R L3 NST | no | 23 | Targeted BP with fibrin | 32 | Resolution of h/a |
| M | 37 | R | R T10 and T11 NST | no | 20 | Targeted BP with fibrin (had dynamic CTM with similar findings) | 58 |
Resolution of h/a
Rebound intracranial hypertension |
| M | 57 | R | R T11 CVF | no | 18 | R T11 + L T8 ligation | 102 | Resolution of h/a |
| M | 49 | L | L L2 CVF | yes | 15 | Embolization after targeted BPs | 52 |
Transient 3 weeks improvement after BPs,
Stable improvement after same level embolization |
| F | 34 | R | R T7 NST | yes | 20 | BP no fibrin | 316 |
Resolved h/a
Rebound intracranial hypertension |
| M | 43 | R |
Outside FOV, puncture at L3-4;
R S1 NST |
yes | 20 | Targeted BP with fibrin | 150 | Improved h/a |
| M | 58 | R |
Outside FOV, puncture at L3-4;
L4-5 extradural contrast, CVF at surgery |
yes | 21 | Targeted BP with fibrin | 159 | Transient improvement 3 months after BP, lost to follow-up after laminectomy |
| M | 61 | L | L T7 NST | yes | 14 | Targeted BP with fibrin | 371 | Resolved h/a |
| M | 50 | L | L T9 CVF | yes | 12 | Venous embolization | 62 | Resolved h/a |
| F | 58 | L | L T9 CVF | yes | 30 | Venous embolization | 57 | No significant improvement |
| F | 35 | L | L NST T10 and T11 | yes | 18 | no | n/a | n/a |
| F | 46 | R | R T4 and T10 CVF | yes | 11 | R T4 + T10 ligation | 557 | 1-year improvement, h/a recurred |
| F | 36 | R | R T3 CVF | yes | 11 | Multifocal BP no fibrin | 21 | no significant improvement |
| M | 69 | R | R T4-6 CVF | yes | 19 | BP interlaminar T4-5, T7-8 | 365 | Essentially resolved |
| F | 56 | L | L T4 CVF | no | 42 | BP no fibrin | 40 | Transient improvement 2 weeks |
| F | 58 | L | Outside FOV, puncture at L1-2; R L2-3 CVF |
yes | 22 | BP no fibrin | 145 | Transient improvement 1 week |
| F | 36 | L | L T2 CVF | yes | 30 | Targeted BP with fibrin | 14 | Transient improvement 1 week |
| F | 48 | L | Bilat C7-T1 CVF | no | 18 | BP interlaminar C7-T1 | 97 | Transient improvement 5 days |
| F | 63 | R | L3 CVF | yes | 11 | Targeted BP with fibrin | 7 | Transient improvement 3 days |
| F | 28 | L | L T12 CVF | yes | 25 | Targeted BP with fibrin | 112 | Transient improvement 3 days |
| F | 28 | R | R T11 CVF | yes | 10 | Targeted BP with fibrin | 112 | Transient improvement 3 days |
| F | 52 | R | R L4 CVF | yes | 25 | Root packing | 131 | No improvement |
| F | 35 | R | R T1, T9, T11, T12, L1, L2 NST | yes | 16 | Targeted BP with fibrin | 348 | No improvement |
| F | 63 | L | L T10, L T12 CVF | yes | 12 | BP interlaminar T10-11 | 12 | No improvement |
| F | 50 | R | R T11 CVF | yes | 12 | Targeted BP with fibrin | 425 | No improvement |
| F | 26 | L | L T11 CVF | no | 17 | No | n/a | n/a |
| F | 17 | L | L T11 CVF | no | 20 | No | n/a | n/a |
| M | 51 | L | L T4 CVF | no | 36 | No | n/a | n/a |
| F | 63 | L | L T1 and T11 CVF | no | 13 | No (more definitive leak on the other side) | n/a | n/a |
| M | 61 | R | R T6, T12, L2 CVF | yes | 13 | No (more definitive leak on the other side) | n/a | n/a |
| F | 58 | R | R T12, L2 CVF | no | 11 | No (more definitive leak on the other side) | n/a | n/a |
| F | 65 | R | R T2 CVF | yes | 24 | BP no fibrin | 438 | Significantly improved |
| F | 86 | R | R T7 NST | yes | 40 | BP no fibrin | n/a | n/a |
| F | 44 | R | R T8 CVF | yes | 25 | BP interlaminar T8-9 | n/a | n/a |